CIN: L65991DLl996PLC083909

Registered Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - 110033

Q2 & H1 FY23 - Earnings update

Revenue from Operations reported at Rs.5,822.09 Mn in Q2 FY23 and Rs.11,428.99 Mn for H1 FY23

EBITDA stands at Rs.684.54 Mn in Q2 FY23 and Rs.1,269.08 Mn for H1 FY23

PAT at Rs.448.33 Mn in Q2 FY23 and Rs.831.42 Mn for H1 FY23

Delhi, 7th Nov, 2022: Insecticides (India) Ltd. ("IIL") is one of the leading manufacturers of agrochemicals, pesticides and technical products catering to the needs of domestic as well as international markets. IIL boasts of an impressive product portfolio consisting of 21+ technical products and 105+ formulation products. IIL, in its' board meeting, has announced its unaudited results for Q2 and H1 ended on 30th September, 2022.

Consolidated financial statement highlights for Q2 FY23 v/s Q2 FY22

Particulars (Rs. Mn)

Q2 FY23

Q2 FY22

YoY%

Q1 FY23

Revenue from Operations

5,822.09

4,439.39

31.15%

5,606.90

Other Income

2.84

(3.14)

1.94

Total Revenue

5,824.93

4,436.25

31.30%

5,608.84

Total Expenses excluding Depreciation, Amortization &

5,137.55

3,797.70

5,022.37

Finance Cost

EBITDA

684.54

641.69

6.68%

584.53

EBITDA Margin (%)

11.76%

14.45%

-269 bps

10.43%

Depreciation & Amortization

63.99

64.39

66.24

Finance Cost

27.40

16.99

14.08

PBT before Share of profits of JV & investment

595.99

557.17

506.15

Add: Share of Profits of JV & Investment

1.70

1.17

3.12

PBT

597.69

558.34

7.05%

509.27

Total Tax Expenses

149.36

139.55

126.19

PAT

448.33

418.79

7.05%

383.08

Other comprehensive profit / loss

2.79

5.44

12.50

Net PAT

451.12

424.22

6.35%

395.58

PAT Margin %

7.70%

9.43%

-173 bps

6.83%

Diluted EPS

15.15

14.15

7.07%

12.94

Q2 & H1 FY23 Earnings Update

Captive IR Strategic Advisors Pvt. Ltd.

Consolidated financial performance comparison - Q2 FY23 v/s Q2 FY22

  • Revenue from Operations has grown by 31.15% from Rs. 4,439.39 Mn in Q2 FY22 to Rs. 5,822.09 Mn in Q2 FY23 mainly led by increase in sales of branded formulations owing to resilient demand in domestic market and acceptance of the newly launched products in the market.
  • The EBITDA increased by 6.68% from Rs. 641.69 Mn in Q2 FY22 to Rs. 684.54 Mn in Q2 FY23. EBITDA margins declined from 14.45% in Q2 FY22 to 11.76% in Q2 FY23 on a YoY basis due to increase in cost of raw materials and currency headwinds which led to a forex loss. However, on QoQ basis, the margins improved by 133 bps primarily led by better product mix and calibrated price hikes majorly offsetting elevated input cost and currency headwinds.
  • PAT increased by 7.05% from Rs. 418.79 Mn in Q2 FY22 to Rs. 448.33 in Q2 FY23.
  • PAT margins decreased from 9.43% in Q2 FY22 to 7.70% in Q2 FY23.

Consolidated financial statement highlights for H1 FY23 v/s H1 FY22

Particulars (Rs. Mn)

H1 FY23

H1 FY22

YoY%

Revenue from Operations

11,428.99

9,122.00

25.29%

Other Income

4.78

13.16

Total Revenue

11,433.77

9,135.16

25.16%

Total Expenses excluding Depreciation, Amortization & Finance

10,159.91

7,949.49

Cost

EBITDA

1,269.08

1,172.51

8.24%

EBITDA Margin (%)

11.10%

12.85%

-175 bps

Depreciation & Amortization

130.22

127.80

Finance Cost

41.48

38.54

PBT before Share of profits of JV & investment

1,102.16

1,019.33

Add: Share of Profits of JV & Investment

4.82

3.64

PBT

1,106.97

1,022.97

8.21%

Total Tax Expenses

275.55

254.59

PAT

831.42

768.38

8.20%

Other comprehensive profit / loss

15.29

0.96

Net PAT

846.71

769.34

10.06%

PAT Margin %

7.28%

8.42%

-114 bps

Diluted EPS

28.09

25.79

8.92%

Q2 & H1 FY23 Earnings Update

Captive IR Strategic Advisors Pvt. Ltd.

Consolidated financial performance comparison for H1 FY23 v/s H1 FY22

  • Revenue from operations recorded a growth of 25.29% from Rs. 9,122.00 Mn in H1 FY23 to Rs. 11,428.99 Mn in H1 FY23 mainly driven by the institutional sales and the increased acceptance of
    IIL's newly launched products.
  • The EBITDA increased by 8.24% from Rs. 1,172.51 Mn in H1 FY22 to Rs. 1,269.08 Mn in H1 FY23 and the EBITDA margins de-grew from 12.85% in H1 FY22 to 11.10% in H1 FY23.
  • PAT stood at Rs. 831.42 Mn in H1 FY23 as compared to Rs. 768.32 Mn in H1 FY22 recording a growth of 8.20% and PAT margins stood at 7.28% in H1 FY23 as compared to 8.42% in H1 FY22.

CONSOLIDATED CASH FLOW & BALANCE SHEET ANALYSIS

Particulars (Rs. Mn)

H1 FY23

H1 FY22

Net Cash Generation from operation

(1,977.03)

(803.56)

Net Cash Generated/ (Used in) investing activity

(439.00)

515.72

Net Cash Generated/ (Used) from Financing activity

2,199.83

327.33

Net Increase in Cash and Cash Equivalents

(216.20)

39.49

Particulars (Rs. Mn)

30.09.22

30.09.21

Particulars (Rs. Mn)

30.09.22

30.09.21

Assets

Equity & liabilities

Non-current assets

Equity

Property, plant and equipment

2,138.98

2,004.66

Equity share capital

197.32

197.32

Capital work-in-progress

1,256.70

712.59

Other equity

9,286.31

8,185.21

Right-of-use assets

255.98

267.21

Total equity

9,483.63

8,382.53

Intangible assets

67.40

64.10

Non-current liabilities

Intangible assets under develop.

53.24

51.33

Borrowings

29.37

18.61

Investment in JV

108.43

102.91

Lease liabilities

25.34

31.94

Investments

73.28

47.69

Provisions

16.11

27.68

Other Financials assets

19.84

24.95

Deferred tax liabilities (Net)

125.19

127.08

Non-current tax assets (Net)

168.63

152.21

Total non-current liabilities

196.00

205.30

Other non-current assets

88.95

158.01

Current liabilities

Total non-current assets

4,231.42

3,585.67

Borrowings

2,709.73

1,908.90

Current assets

Lease liabilities

18.05

19.12

Inventories

7,989.65

5,693.09

Trade payables

4,738.45

2,813.45

Trade receivables

5,210.34

4,155.91

Other Financial Liabilities

473.13

304.45

Cash, bank and cash equivalents

213.39

122.60

Other Current Liabilities

242.30

241.73

Other financial assets

19.88

23.63

Provisions

27.67

47.99

Other Current Assets

457.26

450.16

Current tax liabilities (Net)

233.02

107.59

Total current assets

13,890.55

10,445.39

Total current liabilities

8,442.35

5,443.24

TOTAL ASSETS

18,121.97

14,031.06

TOTAL LIABILITIES

18,121.97

14,031.06

Q2 & H1 FY23 Earnings Update

Captive IR Strategic Advisors Pvt. Ltd.

  • Total fixed assets (tangibles inc. CWIP) grew by 24.96% from Rs. 2,717.25 Mn in H1 FY22 to Rs. 3,395.68 Mn in H1 FY23 owing to the CAPEX incurred.
  • Current assets stood at Rs. 13,890.55 Mn in H1 FY23 as compared to Rs. 10,445.39 Mn in H1 FY22.
  • Long term borrowings stood at Rs. 29.37 Mn in H1 FY23, compared to Rs. 18.61 Mn in H1 FY23 and Short-term borrowings at Rs. 2,709.73 Mn in H1 FY23, compared to Rs. 1,908.90 Mn in H1 FY22 owing to the increase in working capital requirement.
  • Working capital cycle has marginally decreased to 153 days in H1 FY23 as compared to 159 days in
    H1 FY22.
  • Debt Equity ratio stood at 0.29 in H1 FY23 compared to 0.23 in H1 FY22 owing to the increase in the short-termborrowings.
  • Cash flow from operations stands at Rs. (1,977.03) Mn in H1 FY23 as compared to Rs. (803.56) Mn in H1 FY22.

Financial snapshot

Improving Performance QoQ

Revenue from operations

EBIDTA

PAT

EBITDA%

PAT%

7000

16.00%

14.45%

5,822.09

14.00%

6000

5,606.90

5000

11.76%

12.00%

4,439.39

10.43%

10.00%

4000

9.43%

7.70%

8.00%

3000

6.83%

6.00%

2000

4.00%

1000

641.69

584.53

684.54

2.00%

418.79

383.08

448.33

0

0.00%

Q2 FY22

Q1 FY23

Q2 FY23

Half Year Performance

Q2 & H1 FY23 Earnings Update

Captive IR Strategic Advisors Pvt. Ltd.

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Insecticides (India) Limited published this content on 08 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 November 2022 08:13:03 UTC.